Payment overview · 2025
General Payments
$35.75
2 reported records · 1 companies
Healthcare provider profile · identity verified
Ahmad A Mur, MD
Allopathic & Osteopathic Physicians|Internal Medicine · HILLSBOROUGH, NJ · NPI 1801878582
Verified facts
What the public records show
CMS Open Payments records show Ahmad A Mur, MD received $35.75 in general payments during 2025 across 2 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Arexvy by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $35.75 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.75 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $35.75 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
49 | 48 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 844 | 164 |
| Amlodipine Besylate | Amlodipine Besylate | 788 | 142 |
| Eliquis | Apixaban | 632 | 71 |
| Levothyroxine Sodium | Levothyroxine Sodium | 625 | 118 |
| Metoprolol Tartrate | Metoprolol Tartrate | 527 | 101 |
| Pantoprazole Sodium | Pantoprazole Sodium | 494 | 110 |
| Tamsulosin Hcl | Tamsulosin Hcl | 481 | 78 |
| Mirtazapine | Mirtazapine | 440 | 71 |
| Gabapentin | Gabapentin | 403 | 84 |
| Divalproex Sodium | Divalproex Sodium | 338 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 322 | 69 |
| Potassium Chloride | Potassium Chloride | 318 | 46 |
| Trazodone Hcl | Trazodone Hcl | 304 | 50 |
| Furosemide | Furosemide | 300 | 59 |
| Metformin Hcl | Metformin Hcl | 271 | 51 |
| Sertraline Hcl | Sertraline Hcl | 255 | 42 |
| Clopidogrel | Clopidogrel Bisulfate | 246 | 50 |
| Omeprazole | Omeprazole | 226 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 218 | 38 |
| Carvedilol | Carvedilol | 211 | 38 |
| Famotidine | Famotidine | 205 | 43 |
| Lisinopril | Lisinopril | 195 | 35 |
| Losartan Potassium | Losartan Potassium | 192 | 45 |
| Hydralazine Hcl | Hydralazine Hcl | 190 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 189 | 32 |
| Midodrine Hcl | Midodrine Hcl | 185 | 32 |
| Donepezil Hcl | Donepezil Hcl | 175 | 29 |
| Simvastatin | Simvastatin | 175 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 168 | 23 |
| Januvia | Sitagliptin Phosphate | 161 | 14 |
| Levetiracetam | Levetiracetam | 153 | 20 |
| Memantine Hcl | Memantine Hcl | 148 | 21 |
| Montelukast Sodium | Montelukast Sodium | 144 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 142 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 141 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 129 | 41 |
| Buspirone Hcl | Buspirone Hcl | 120 | 17 |
| Olanzapine | Olanzapine | 119 | 18 |
| Risperidone | Risperidone | 107 | 19 |
| Warfarin Sodium | Warfarin Sodium | 107 | suppressed |
| Finasteride | Finasteride | 103 | 21 |
| Repaglinide | Repaglinide | 101 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 91 | 21 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 91 | 30 |
| Ondansetron Hcl | Ondansetron Hcl | 89 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 83 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 82 | 11 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 79 | 30 |
| Spironolactone | Spironolactone | 77 | 16 |
| Meloxicam | Meloxicam | 76 | 14 |
| Alprazolam | Alprazolam | 75 | 20 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 75 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 74 | 23 |
| Clonazepam | Clonazepam | 73 | 13 |
| Latanoprost | Latanoprost | 72 | 13 |
| Baclofen | Baclofen | 70 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 67 | 31 |
| Ezetimibe | Ezetimibe | 66 | 14 |
| Valsartan | Valsartan | 64 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 63 | suppressed |
| Linzess | Linaclotide | 62 | suppressed |
| Lorazepam | Lorazepam | 62 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 62 | suppressed |
| Sucralfate | Sucralfate | 61 | 12 |
| Novolog Flexpen | Insulin Aspart | 60 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 59 | 26 |
| Lacosamide | Lacosamide | 58 | suppressed |
| Allopurinol | Allopurinol | 56 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 56 | 12 |
| Enalapril Maleate | Enalapril Maleate | 54 | 11 |
| Budesonide | Budesonide | 51 | 13 |
| Methimazole | Methimazole | 51 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 51 | 17 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 49 | 48 |
| Ozempic | Semaglutide | 49 | 12 |
| Alendronate Sodium | Alendronate Sodium | 48 | 13 |
| Bethanechol Chloride | Bethanechol Chloride | 48 | suppressed |
| Celecoxib | Celecoxib | 48 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 48 | suppressed |
| Clozapine | Clozapine | 47 | suppressed |
| Glimepiride | Glimepiride | 47 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 46 | suppressed |
| Rexulti | Brexpiprazole | 45 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 44 | suppressed |
| Aripiprazole | Aripiprazole | 43 | suppressed |
| Bumetanide | Bumetanide | 42 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 42 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 42 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 41 | 32 |
| Jardiance | Empagliflozin | 40 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 39 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | suppressed |
| Clonidine | Clonidine | 38 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 37 | suppressed |
| Entresto | Sacubitril/Valsartan | 35 | suppressed |
| Myrbetriq | Mirabegron | 35 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 35 | suppressed |
| Oxycontin | Oxycodone Hcl | 35 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 33 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 33 | suppressed |
| Lactulose | Lactulose | 33 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 32 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 32 | suppressed |
| Azithromycin | Azithromycin | 31 | 27 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | 17 |
| Fentanyl | Fentanyl | 31 | suppressed |
| Glipizide | Glipizide | 31 | suppressed |
| Torsemide | Torsemide | 31 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 29 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 28 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 28 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 28 | suppressed |
| Paliperidone Er | Paliperidone | 28 | suppressed |
| Prednisone | Prednisone | 28 | 18 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 27 | suppressed |
| Nystatin | Nystatin | 27 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Tradjenta | Linagliptin | 27 | suppressed |
| Ursodiol | Ursodiol | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Xarelto | Rivaroxaban | 26 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 26 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 25 | 14 |
| Digoxin | Digoxin | 24 | suppressed |
| Anastrozole | Anastrozole | 23 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 23 | suppressed |
| Galantamine Er | Galantamine Hbr | 23 | suppressed |
| Klor-Con 10 | Potassium Chloride | 23 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Procrit | Epoetin Alfa | 21 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Enbrel Sureclick | Etanercept | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 16 |
| Cephalexin | Cephalexin | 19 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Insulin Lispro | Insulin Lispro | 18 | suppressed |
| Metolazone | Metolazone | 18 | suppressed |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 18 | suppressed |
| Admelog Solostar | Insulin Lispro | 17 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 17 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Daptomycin | Daptomycin | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | 13 |
| Naltrexone Hcl | Naltrexone Hcl | 17 | suppressed |
| Nyamyc | Nystatin | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Timolol Maleate | Timolol Maleate | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Acetylcysteine | Acetylcysteine | 16 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Comfort Ez Pro Safety Pen Ndl | Pen Needle, Diabetic, Safety | 16 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Cyclosporine | Cyclosporine | 15 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 11 |
| Pregabalin | Pregabalin | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 14 | suppressed |
| Nystop | Nystatin | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 13 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 13 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 13 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 11 | 11 |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Tacrolimus | Tacrolimus | 11 | suppressed |
| Tobramycin | Tobramycin | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.75 · 2 records | GlaxoSmithKline, LLC. | SHINGRIX | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error